GSK

1,969

+1.7%↑

STJ

1,217.5

-0.61%↓

HIK

1,228

-0.41%↓

HILS

2,110

0%↓

GSK

1,969

+1.7%↑

STJ

1,217.5

-0.61%↓

HIK

1,228

-0.41%↓

HILS

2,110

0%↓

GSK

1,969

+1.7%↑

STJ

1,217.5

-0.61%↓

HIK

1,228

-0.41%↓

HILS

2,110

0%↓

GSK

1,969

+1.7%↑

STJ

1,217.5

-0.61%↓

HIK

1,228

-0.41%↓

HILS

2,110

0%↓

GSK

1,969

+1.7%↑

STJ

1,217.5

-0.61%↓

HIK

1,228

-0.41%↓

HILS

2,110

0%↓

Search

Pets at Home Group Plc

Gesloten

SectorGezondheidszorg

181.5 -0.06

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

160.6

Max

184

Belangrijke statistieken

By Trading Economics

Inkomsten

-24M

26M

Verkoop

85M

778M

K/W

Sectorgemiddelde

11.182

57.833

EPS

0.056

Dividendrendement

6.74

Winstmarge

3.366

Werknemers

11,597

EBITDA

8.3M

102M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+26.65% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

6.74%

2.47%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-75M

841M

Vorige openingsprijs

181.56

Vorige sluitingsprijs

181.5

Nieuwssentiment

By Acuity

29%

71%

76 / 350 Rangschikking in Healthcare

Pets at Home Group Plc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie
Winsten
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Pets at Home Group Plc Prognose

Koersdoel

By TipRanks

26.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 230 GBX  26.65%

Hoogste 265 GBX

Laagste 195 GBX

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pets at Home Group Plc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

1

Buy

0

Hold

1

Sell

Sentiment

By Acuity

76 / 350 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pets at Home Group Plc

Pets at Home Group Plc engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom. It operates through three segments: Retail, Vet Group, and Central. The company offers pet grooming services comprising a full dog groom, bath and blow dry, microchipping, and nail clipping; and pet insurance products, as well as other in-store services, including consultations with its trained pet nutritionists. Further, it offers general veterinary care; triage; and veterinary telehealth services. The company operates through pet care centers, stores, general practices, and grooming salons. It also provides products and services through online under the Pet at Home, Vets for Pets, Pet Grooming, Pets Foundation, and Pets VIP Club brands. Pets at Home Group Plc was founded in 1991 and is based in Handforth, the United Kingdom.
help-icon Live chat